<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">31454205</article-id><article-id pub-id-type="pmc">6713375</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0071</article-id><article-categories><subj-group subj-group-type="heading"><subject>Case Report</subject></subj-group></article-categories><title-group><article-title>Off-Pump Coronary Revascularization Using Bilateral Internal Thoracic
Arteries in A Patient with Paroxysmal Nocturnal Hemoglobinuria: A Case
Report</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Vrancic</surname><given-names>Juan Mariano</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-5247-5989</contrib-id><name><surname>Cervetti</surname><given-names>Manuel Roque</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Benavides</surname><given-names>Juli&#x000e1;n</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Navia</surname><given-names>Daniel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><aff id="aff1">
<label>1</label> Department of Cardiac Surgery, Instituto Cardiovascular de
Buenos Aires, Buenos Aires, Argentina.</aff></contrib-group><author-notes><corresp id="c1">Correspondence Address: Manuel Roque Cervetti,
https://orcid.org/0000-0001-5247-5989, Instituto Cardiovascular de Buenos Aires,
Ringgold Standard Institution, Av. del Libertador 6302, Buenos Aires,
ArgentinaZip Code: 1428. E-mail:
<email>manuelcervetti_1@hotmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Jul-Aug</season><year>2019</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Jul-Aug</season><year>2019</year></pub-date><volume>34</volume><issue>4</issue><fpage>488</fpage><lpage>490</lpage><history><date date-type="received"><day>06</day><month>3</month><year>2018</year></date><date date-type="accepted"><day>15</day><month>5</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><p>Paroxysmal nocturnal hemoglobinuria (PNH) is an ultra-orphan disease. We report
the first case in the literature of Off-Pump Coronary Revascularization Using
Bilateral Internal Thoracic Arteries in a patient with paroxysmal nocturnal
hemoglobinuria.</p><p>A 36-year-old man came to the emergency department with acute non-ST elevation
myocardial infarction (NSTEMI). He presented paroxysmal nocturnal hemoglobinuria
diagnosed in 2016. Coronary angiography revealed tripple vessel disease.</p><p>The conduits used for coronary revascularization were both internal thoracic
arteries (left ITA-right ITA [LITA-RITA]).</p><p>We consider that off-pump coronary artery bypass grafting (OPCABG) using
Bilateral Internal Thoracic Arteries (BITA) can be safely performed with low
in-hospital mortality and complications rates, even in patient with PNH.</p></abstract><kwd-group><kwd>Off-Pump Coronary Revascularization</kwd><kwd>Bilateral Internal Thoracic Arteries</kwd><kwd>Paroxysmal Nocturnal Hemoglobinuria</kwd></kwd-group></article-meta></front><body><table-wrap id="t1" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">BITA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Bilateral internal
thoracic arteries</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">DA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Diagonal Artery</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">GPI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">=
Glycosyl-phosphatidylinositol</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ICU</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Intensive Care Unit</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">ITA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Internal thoracic
arteries</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LAD</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left anterior
descending</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LCX</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left circumflex coronary
artery</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">LITA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Left internal thoracic
arteries</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">NSTEMI</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Non-ST elevation
myocardial infarction</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">OPCABG</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Off-pump coronary artery
bypass grafting</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PIG-A</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= phosphatidylinositol
glycan, class A</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">PNH</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Paroxysmal nocturnal
hemoglobinuria</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RCA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Right coronary
artery</td></tr><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">RITA</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Right internal thoracic
arteries</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Paroxysmal nocturnal heemoglobinuria (PNH), an ultra-orphan disease with a prevalence
of 15.9 per million in Europe, is a life-threatening disorder, characterized by
hemolysis, bone marrow failure and thrombosis<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>.</p><p>PNH is based on a clonal defect of hematopoietic stem cells characterized by
deficiency in glycosyl-phosphatidylinositol (GPI)-anchored surface proteins due to
mutations within the X-chromosomal PIG-A Gene (2).</p><p>PNH is an acquired hemolytic anemia associated with an increased risk to develop
thrombocytopenia, atypical venous thrombosis and hypoplastic bone
marrow<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>Nowadays, the use of new drugs such as Eculizumab (Soliris&#x02122;) has improved the
quality of life and the symptoms suffered by these patients.</p><p>To our knowledge,we report in the literature of off-pump coronary revascularization
using bilateral internal thoracic arteries (BITA) in a patient with paroxysmal
nocturnal hemoglobinuria.</p></sec><sec sec-type="cases"><title>CASE REPORT</title><p>A 36-year-old man presented to the emergency department with an acute non-ST
elevation myocardial infarction (NSTEMI) with elevated troponin.</p><p>Previous medical history included dilated cardiomyopathy with dyspnea, functional
class II-III in study, and tripple vessel coronary disease. In addition, the patient
presented paroxysmal nocturnal hemoglobinuria diagnosed in 2016, treated with
eculizumab.</p><p>On admission, laboratory tests showed normal kidney function (blood urea nitrogen of
29mg/dl and creatinine of 0.93 mg/dl) and normal liver function. Leucocytes
4690/mm3. Differential blood count revealed 53.7% neutrophils, 33.7% lymphocytes,
11.1% monocytes, and 0.9% eosinophils. Hemoglobin 10.1 g/dl, platelets
113.000/mm<sup>3</sup>.</p><p>Coronary angiotomography reported the following: Left main presented a middle and
distal lesion extended to the origin to the LAD; LAD with an ostial and proximal
mixed lesion; Circunflex presented a significant proximal stenosis and right
coronary is do inant and presented a very significant proximal and middle lesions.
(<xref ref-type="fig" rid="f1">Figures 1</xref> to <xref ref-type="fig" rid="f4">4</xref>).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Coronary Angiotomography.</p></caption><graphic xlink:href="rbccv-34-04-0488-g01"/></fig>
</p><p>
<fig id="f4" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Coronary Right presents proximal and medium significant lesions. Filled
arrows indicate injuries.</p></caption><graphic xlink:href="rbccv-34-04-0488-g04"/></fig>
</p><p>Coronary angiography revealed a moderate ostial and proximal stenoses in the left
anterior descending (LAD) coronary artery. There were chronic stenoses in the
proximal segment of the left circumflex coronary artery (LCX) and a 95% stenosis in
the proximal right coronary artery.</p><p>Echocardiography showed reduced left ventricular function (Ejection fraction: 32%),
severely dilated left ventricle and global hypokinesia.</p><p>The conduits used for coronary revascularization were both internal thoracic arteries
(left ITA-right ITA [LITA-RITA]). The LITA was harvested and anastomosed to the left
anterior descending artery. The technical configuration was in-situ anastomoses of
the LITA to the left anterior descending artery; and the RITA, after being divided
at its origin and bifurcation, was connected end to-side to the in-situ LITA as a
sequential T graft to two circumflex arteries. Saphenous vein grafts were
anastomosed to the posterior descending coronary artery. It was reported that
skeletonized harvesting of ITA offers more conduit length and was associated with a
lower incidence of sternal infection, so we use this technic routinely.</p><p>The procedure was off-pump, without complication.</p><p>During the postoperative period, subcutaneous heparin 5,000 units was administered 2
times daily, to avoid thromboembolism.</p><p>After 24 hours in the ICU and 4 days of uneventful total length of stay, the patient
was discharged.</p><p>Eculizumab (900 mg) was administrated during the postoperative period to optimize
hematological parameters.</p><p>The postoperative controls were at 7 days and at 25 days after discharge. The patient
was asymptomatic.</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Thromboembolism is the most common cause of mortality in PNH, and the 4-year survival
of patients presenting with thrombosis at diagnosis was only 40% before the era of
eculizumab<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. Arterial thromboembolism is far less frequent and
only 20 cases of coronary thrombosis associated with PNH have been reported until
now. Ziakas et al reported in a meta-analysis on 363 PNH cases with thrombosis, 12
episodes of myocardial infarction<sup>[<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>]</sup>.</p><p>Eculizumab is a humanized monoclonal antibody that blocks terminal complement pathway
by binding to C5. This drug has dramatically changed the natural history of PNH.
Eculizumab increases transfusion independency, reduces the risk of further
thrombotic events and improves health-related quality of life.
Eculizumab<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>.</p><p>Cardiac surgery in PNH patients is associated with several possible complications.
PNH-induced granulocytopenia increases the risk of postoperative infection. The
increase of hemolysis by extracorporeal circulation in cardiac surgery due to
complement activation from either contact of blood with the foreign material
surfaces during cardiopulmonary bypass circuit, or use of protamine to neutralize
systemic heparin after cardiopulmonary bypass and tissue injury is well
known<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>.</p><p>We consider that OPCABG using BITA can be safely performed with low in-hospital
mortality and complications rates, even in patients with PNH. Surgical techniques
and the new technology in coronary stabilizers allow surgeons to perform a complete
myocardial coronary revascularization using the best available arterial conduit
(BITA)<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>.</p><p>There have been 5 cases reported previously of patients with PNH undergoing cardiac
surgery, but this is the first case where we combine Off-Pump Coronary
Revascularization Using Bilateral Internal Thoracic Arteries in a patient with
paroxysmal nocturnal hemoglobinuria.</p><table-wrap id="t2" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Author's roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">JMV</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MRC</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">JB</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DN</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Instituto Cardiovascular de Buenos Aires -
Capital Federal, Buenos Aires, Argentina.</p></fn><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>M</given-names></name><name><surname>Munir</surname><given-names>T</given-names></name></person-group><article-title>Management of thrombosis in paroxysmal nocturnal hemoglobinuria:
a clinician's guide</article-title><source>Ther Adv Hematol</source><year>2017</year><volume>8</volume><issue>3</issue><fpage>119</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1177/2040620716681748</pub-id><pub-id pub-id-type="pmid">28246555</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knobloch</surname><given-names>K</given-names></name><name><surname>Lichtenberg</surname><given-names>A</given-names></name><name><surname>Leyh</surname><given-names>RG</given-names></name><name><surname>Schubert</surname><given-names>J</given-names></name></person-group><article-title>Aortic valve replacement and coronary revascularization in
paroxysmal nocturnal hemoglobinuria</article-title><source>Interact Cardiovasc Thorac Surg</source><year>2003</year><volume>2</volume><issue>4</issue><fpage>647</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1016/S1569-9293(03)00177-4</pub-id><pub-id pub-id-type="pmid">17670147</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinquenel</surname><given-names>A</given-names></name><name><surname>Maestraggi</surname><given-names>Q</given-names></name><name><surname>Lecoq-Lafon</surname><given-names>C</given-names></name><name><surname>Latour R&#x000e9;gis</surname><given-names>P</given-names></name><name><surname>Delmer</surname><given-names>A</given-names></name><name><surname>Servettaz</surname><given-names>A</given-names></name></person-group><article-title>Atypical presentation of paroxysmal nocturnal hemoglobinuria
treated by eculizumab: a case report</article-title><source>Medicine</source><year>2017</year><volume>96</volume><issue>12</issue><elocation-id>e6403</elocation-id><pub-id pub-id-type="doi">10.1097/MD.0000000000006403</pub-id><pub-id pub-id-type="pmid">28328837</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziakas</surname><given-names>PD</given-names></name><name><surname>Poulou</surname><given-names>LS</given-names></name><name><surname>Rokas</surname><given-names>GI</given-names></name><etal/></person-group><article-title>Thrombosis in paroxysmal nocturnal hemoglobinuria: sites, risks,
outcome: an overview</article-title><source>J Thromb Haemost</source><year>2007</year><volume>5</volume><issue>3</issue><fpage>642</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1111/j.1538-7836.2007.02379.x</pub-id><pub-id pub-id-type="pmid">17319910</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hillmen</surname><given-names>P</given-names></name><name><surname>Muus</surname><given-names>P</given-names></name><name><surname>Roth</surname><given-names>A</given-names></name><etal/></person-group><article-title>Long-term safety and efficacy of sustained eculizumab treatment
in patients with paroxysmal nocturnal haemoglobinuria</article-title><source>Br J Haematol</source><year>2013</year><volume>162</volume><issue>1</issue><fpage>62</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1111/bjh.12347</pub-id><pub-id pub-id-type="pmid">23617322</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navia</surname><given-names>D</given-names></name><name><surname>Vrancic</surname><given-names>M</given-names></name><name><surname>Vaccarino</surname><given-names>G</given-names></name><name><surname>Piccinini</surname><given-names>F</given-names></name><name><surname>Raich</surname><given-names>H</given-names></name><name><surname>Florit</surname><given-names>S</given-names></name><etal/></person-group><article-title>Total arterial off-pump coronary revascularization using
bilateral internal thoracic arteries in triple-vessel disease: surgical
technique and clinical outcomes</article-title><source>Ann Thoracic Surg</source><year>2008</year><volume>86</volume><issue>2</issue><fpage>524</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1016/j.athoracsur.2008.04.069</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Anterior Descending Artery: Presents ostial and proximal lesion. Filled arrows
indicate injuries.</p></caption><graphic xlink:href="rbccv-34-04-0488-g02"/></fig><fig id="f3" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>Circumflex: presents significant proximal stenosis by mixed lesion. Filled arrows
indicate injuries.</p></caption><graphic xlink:href="rbccv-34-04-0488-g03"/></fig></floats-group></article>